On October 12, 2022, the FDA announced a shortage of Adderall and Adderall IR. These shortages have exacerbated withdrawal symptoms and left patients struggling to manage their ADHD by rationing their medication. Understanding how...
Workforce optimization, compliance challenges, and supply chain disruptions are all issues that plague the global pharmaceutical supply chain — an essential part of the healthcare system. Because global pharmaceutical supply chain...
The COVID-19 pandemic displayed the potential of a collaborative pharmaceutical industry. The worldwide cooperation between researchers, healthcare professionals, pharmaceutical companies, and industry leaders contributed to the now...
A retrospective cohort study was conducted using data from January 1, 2004, to December 31, 2018. The researchers reviewed information from the FDA and the European Medicines Agency (EMA) to determine...
Chemotherapy drugs play a significant role in the treatment of cancer. Understanding the kinds of chemotherapy drugs can help patients make an informed decision with the assistance of their oncologist and their team of healthcare...
The FDA’s Report on The State of Pharmaceutical Quality is published annually to analyze quality measures related to drug manufacturers and products. The report looked at manufacturing site...
Starting in the 1900s, the opioid epidemic has been a determent to public health in the United States. Recent data and discoveries have named participants in the pharmaceutical industry as major...
In a recent announcement, CVS Health stated that they are implementing time delay safes in western states, including Colorado, Utah, Montana, Idaho, and Wyoming. These safes attempt to protect...
Last week, Merck & Co made the FDA aware of the presence of nitrosamine in its type 2 diabetes drug, Januvia. Merck’s analysis of the drug found nitrosamine levels higher than allowed by the...
According to the CDC, patients with type one diabetes have a pancreas that produces no or little insulin. To properly manage the disease, many patients take insulin. With the price of insulin rising,...
Monkeypox was declared a public health emergency by the WHO on Saturday, July 23, 2022. Since the rise of monkeypox rates, public health organizations have urged at-risk populations to seek...
In the year prior to the start of the coronavirus pandemic, 15.8% of American adults were using prescription medication to support their mental health; two years later, that number has risen to 23%,...
Pharmaceutical giant, Eli Lilly, will extend its operations in Indiana, adding two additional manufacturing facilities with a $2.1 billion investment. Lilly will use the new facilities to produce...
In the United States and worldwide, hospitals are experiencing a shortage of critical iodinated contrast media — also called contrast dye — a nontoxic, contrasting agent that radiologists...
FDA recently proposed a rule to provide greater assurance that supply chain participants are sufficiently qualified to distribute prescription drugs, strengthening the pharmaceutical supply chain.
The...
As big pharma looks to advance its pipelines of innovative drugs and digital measures, industry cooperation is crucial.
In recent years, pharmaceutical companies have embraced a more collaborative way...
More than nine in 10 executives plan to implement a more robust digital supply chain visibility (SCV) solution over the next 12 months, according to a new report from FourKites.
The Pharmaceutical...
AstraZeneca recently unveiled a $1 billion state-of-the-art research and development facility to advance next-generation therapeutics, including nucleotide-based gene-editing and cell therapies.
The...
Gilead recently added three programs in Arcus Biosciences’ clinical-stage portfolio, including antibodies and small molecules, to its oncology pipeline.
Specifically, Gilead exercised its...
Pfizer and Biohaven Pharmaceuticals recently collaborated to commercialize rimegepant, a generic drug used to treat migraine attacks, in markets outside of the US.
Commercialized as Nurtec ODT in the...